RMD Stock Analysis: Buy, Sell, or Hold?
RMD - ResMed Inc.
$211.94
-11.30 (-5.06%)
▼
5d:
+0.46%
30d:
+1.67%
90d:
+2.44%
BUY
HIGH Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 6.4/10
Get Alerted When RMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: RMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$313.04
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$194.38
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RMD is currently trading at $211.94, which is considered fair relative to its 30-day fair value range of $196.16 to $215.40. The stock's valuation (Forward PE: 18.5) is in line with its historical norms (19.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This pessimistic expectation contrasts with the company's recent 10.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RMD is in a downtrend. Immediate support is located at $195.79, while resistance sits at $226.12. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: RMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $248.53 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RMD is in a downtrend. Immediate support is located at $195.79, while resistance sits at $226.12. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: RMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $248.53 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$196.16 -
$215.40
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading below Wall St target ($248.53)
Trading Range Analysis
30-Day Trading Range
$196.16 -
$215.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$195.80
Resistance Level
$226.12
Current Trend
Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.48
Wall Street Target
$248.53
(+11.3%)
Revenue Growth (YoY)
10.8%
Earnings Growth (YoY)
10.5%
Profit Margin
27.4%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
18.5 vs 19.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$220.56
(-1%)
2-Year Target
$217.91
(-2%)
3-Year Target
$215.30
(-4%)
3-Yr Target (if PE normalizes)
(PE: 18→19)
$222.57
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 8.6%)
$313.30
(+40%)
Base:
(SPY PE: 18.5, Growth: 8.6%)
$286.14
(+28%)
Bear:
(PE: 15.7, Growth: 8.6%)
$243.22
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 21.50 | Current EPS (TTM): $10.42
Bull Case
$285.75
(+28%)
Analyst growth 16.0%, PE expands to 23.7
Base Case
$259.78
(+16%)
Market implied 16.0%, PE stable at 21.5
Bear Case
$152.34
(-32%)
Severe decline -20.0%, PE contracts to 18.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.5 to 19.1
Stabilization Target:
$230.78
(+3.4%)
PE Expansion Potential:
+3.4%
Share & Embed Analysis
Last updated: August 07, 2026 4:07 PM ET
Data refreshes hourly during market hours. Next update: 5:07 PM
Data refreshes hourly during market hours. Next update: 5:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael J Farrell
SELL
4991 shares
2026-04-07
Peter C Farrell
SELL
2000 shares
2026-04-01
Ro Khanna
SELL
2026-03-30
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$87 | 53 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$477 | 47 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 61 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 58 HOLD |
Advanced RMD Option Strategies
Professional options setups generated by AI based on today's RMD price and gamma walls.
